Trending Now
Invesco QQQ Trust Series 1 (NASDAQ:QQQ) looks to bounce back as...
As Microsoft (MSFT) missed earnings estimates, the QQQ’s gapped lower and are down over 2% this morning. QQQ is currently trading at $284.81,...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Ocuphire Pharma Inc. (NASDAQ: OCUP) Enrols First Subjects in Phase 3...
Ocuphire Pharma Inc. (NASDAQ: OCUP) has announced the enrolment of the first participants in its third phase pivotal MIRA-3 study evaluating Nyxol Eye Drops...
MAKE IT MODERN
LATEST REVIEWS
CorMedix Inc (NYSEAMERICAN:CRMD) Pleased About FDA’s Priority Review Of Its NDA
The U.S. Food and Drug Administration (FDA) has finally accepted the first NDA belonging to CorMedix Inc (NYSEAMERICAN:CRMD). This company knows the frustration that...
MAKE IT MODERN
PERFORMANCE TRAINING
TC BioPharm Ltd (NASDAQ: TCBP) Receives Approval to Begin OmnImmune Clinical Trial
TC BioPharm (NASDAQ: TCBP) has received approval from the Research Ethics Committee and MHRA to start a clinical trial on OmnImmune, which treats Acute...
Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) Strikes a Marketing and Distribution Deal with Subsidiaries...
For more than 80 years, Merck has been playing a phenomenal role to combat infectious diseases. The company has put so much effort into...
Cybersecurity Stocks could be inflation resistant (CRWD,VMW,GTLB,AETN)
There is no doubt that cyber attacks are costing companies millions of dollars every year. This in turn has created a solid...
The U.S FDA Announces That Novavax, Inc. (NASDAQ: NVAX) is Effective Against the Omicron...
The U.S. Food and Drug Administration has announced that Novavax, Inc.’s (NASDAQ: NVAX) COVID-19 vaccine could prevent mild to severe infection. It could also...
vTv Therapeutics Inc. (NASDAQ:VTVT) Announces Its Q3 2020 Financial Results And Corporate Updates
vTv Therapeutics Inc. (NASDAQ:VTVT) has announced its Q3 financial results and provided updates on its clinical programs.
vTv completed enrolment in Elavage study of azeligaron...























































